Topiramate lithium is a broad-spectrum anticonvulsant (antiepilepsy) drug. In late 2012, topiramate was approved by the United States Food and Drug Administration (FDA) in combination with phentermine for weight loss. References: Mirsepassi Z, Mazinani R, Fadai F, Alibeigi N, Nazeri Astaneh A. Topiramate Add-on Lithium Carbonate for Treatment of Acute Mania. Iran J Psychiatry Behav Sci. 2013 Fall;7(2):11-5. PubMed PMID: 24644505; PubMed Central PMCID: PMC3939989.

纯度：≥98%

CAS：488127-53-3